{"meshTags":["Antineoplastic Agents","Carcinoma, Non-Small-Cell Lung","Erlotinib Hydrochloride","Female","Humans","Lung Neoplasms","Male","Protein Kinase Inhibitors","Quinazolines","Receptor, Epidermal Growth Factor","Taxoids"],"meshMinor":["Antineoplastic Agents","Carcinoma, Non-Small-Cell Lung","Erlotinib Hydrochloride","Female","Humans","Lung Neoplasms","Male","Protein Kinase Inhibitors","Quinazolines","Receptor, Epidermal Growth Factor","Taxoids"],"genes":["EGFR","wild-type EGFR NSCLC"],"publicationTypes":["Comment","Journal Article"],"title":"EGFR inhibitors for wild-type EGFR NSCLC: to use or not to use?","pubmedId":"23883923"}